Entering text into the input field will update the search result below

Acrivon stock jumps 33% following $94M IPO, shares price below range (update)

Nov. 15, 2022 5:26 PM ETAcrivon Therapeutics, Inc. (ACRV) StockBy: Val Brickates Kennedy, SA News Editor

Financial term abbreviation IPO standing for Initial Public Offering on blue cube corner

DariaRen/iStock via Getty Images

Oncology drug developer Acrivon Therapeutics (NASDAQ:ACRV) stock finished its first session 33% higher on Tuesday following a $94M initial public offering that priced shares significantly below a previously stated range.

Shares of the precision medicine

Recommended For You

More Trending News

About ACRV Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ACRV--
Acrivon Therapeutics, Inc.